Market Overview:
The global peptide-based cardiovascular therapeutics market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The growth in this market can be attributed to the increasing prevalence of cardiovascular diseases and rising demand for novel peptide-based therapies. Based on type, the global peptide-based cardiovascular therapeutics market is segmented into bivalirudin, eptifibatide, and others. Bivalirudin held a dominant share in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its benefits such as low incidence of bleeding complications and short infusion time. Eptifibatide is also anticipated to witness high growth during the forecast period owing to its ability to inhibit platelet aggregation and reduce thrombus formation. Based on application, the global peptide-based cardiovascular therapeutics market is segmented into hospital pharmacies, retail pharmacies, online pharmacies,. Hospital pharmacies held a dominant share in 2017 owingto their large customer baseand widespread distribution network across regions.
Product Definition:
A peptide is a molecule that is composed of two or more amino acids linked together by peptide bonds. Peptides play an important role in the body, including the regulation of many physiological processes. Cardiovascular peptides are a class of peptides that have been shown to be effective in treating cardiovascular diseases. These peptides work by modulating various aspects of the cardiovascular system, including heart rate, blood pressure, and vascular tone.
Bivalirudin:
Bivalirudin is a peptide based cardiovascular drug that works by binding to the calcium channel and inhibiting its activity. Bivalirudin has been reported to be effective in the treatment of ventricular fibrillation, which is why it's used as an anti-arrhythmic agent. It also displays effectiveness in reducing blood pressure in patients suffering from hypertension and renal failure, hence it’s used as a cardioprotective drug.
Eptifibatide:
Eptifibatide is a peptide based cardiovascular drug which works by increasing the levels of phosphorylated endothelial nitric oxide (eNOS) via inhibition of serine protease. It has been found to be effective in treating hypertension and coronary artery disease. The product was developed by Merck & Co., Inc. and was first launched in Europe in 2001 as Vascor, later on it got approved for sale within the U.S.
Application Insights:
Based on application, the global peptide based cardiovascular therapeutics market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacy segment is anticipated to witness significant growth over the forecast period owing to various benefits offered such as convenience and flexibility. However, regulatory authorities have not yet approved these drugs for sale through internet websites. Hence these drugs are generally sold through hospital or retail pharmacies only.
The other segment includes peptide-based products which are still in the pipeline stage of clinical trials or have been abandoned by developers due to low therapeutic index of these molecules (too toxic). Products under this category include Bivalirudin (Angiomax) and Eptifibatide (KUVDomato) which were once considered as a potential solution for treating heart failure but later abandoned due to lack of efficacy compared with existing therapies in developed countries like U.S.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its dominance over the forecast period as well due to increasing R&D investments by various companies and rising adoption of peptide-based therapeutics for treatment of cardiovascular diseases. Moreover, high incidence rate of heart diseases coupled with presence of sophisticated healthcare infrastructure is also one among the factors responsible for regional growth.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to growing medical tourism industry in emerging economies such as India and China, which will lead to an increase in demand for peptide-based drugs used across various therapeutic applications.
Growth Factors:
- Growing prevalence of cardiovascular diseases (CVDs) across the globe is expected to drive the demand for peptide based cardiovascular therapeutics over the forecast period.
- Increasing geriatric population is also anticipated to boost the market growth as this population is more susceptible to CVDs.
- Rising awareness about benefits of peptide based therapies over traditional treatments is projected to propel demand for these drugs in coming years.
- Technological advancements in peptide synthesis and delivery are likely to provide new opportunities for market players over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Peptide Based Cardiovascular Therapeutics Market Research Report
By Type
Bivalirudin, Eptifibatide, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Pfizer, AstraZeneca, Novartis, Ipsen, Merck, Mylan, Fresenius, Apotex Holdings, Novetide, Amneal Pharmaceuticals, Dr. Reddy's Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Peptide Based Cardiovascular Therapeutics Market Report Segments:
The global Peptide Based Cardiovascular Therapeutics market is segmented on the basis of:
Types
Bivalirudin, Eptifibatide, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- AstraZeneca
- Novartis
- Ipsen
- Merck
- Mylan
- Fresenius
- Apotex Holdings
- Novetide
- Amneal Pharmaceuticals
- Dr. Reddy's Laboratories
Highlights of The Peptide Based Cardiovascular Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bivalirudin
- Eptifibatide
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peptide Based Cardiovascular Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Peptide-based cardiovascular therapeutics are medications that are composed of peptides, which are short chains of amino acids. Peptides have a number of unique properties that make them attractive candidates for drug development, including their ability to cross the blood-brain barrier and their potential to interact with receptors in the heart and other organs.
Some of the key players operating in the peptide based cardiovascular therapeutics market are Pfizer, AstraZeneca, Novartis, Ipsen, Merck, Mylan, Fresenius, Apotex Holdings, Novetide, Amneal Pharmaceuticals, Dr. Reddy's Laboratories.
The peptide based cardiovascular therapeutics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Peptide Based Cardiovascular Therapeutics Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Peptide Based Cardiovascular Therapeutics Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Peptide Based Cardiovascular Therapeutics Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Peptide Based Cardiovascular Therapeutics Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Peptide Based Cardiovascular Therapeutics Market Size & Forecast, 2020-2028 4.5.1 Peptide Based Cardiovascular Therapeutics Market Size and Y-o-Y Growth 4.5.2 Peptide Based Cardiovascular Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Bivalirudin
5.2.2 Eptifibatide
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Peptide Based Cardiovascular Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Bivalirudin
9.6.2 Eptifibatide
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Bivalirudin
10.6.2 Eptifibatide
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Bivalirudin
11.6.2 Eptifibatide
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Bivalirudin
12.6.2 Eptifibatide
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Bivalirudin
13.6.2 Eptifibatide
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Peptide Based Cardiovascular Therapeutics Market: Competitive Dashboard
14.2 Global Peptide Based Cardiovascular Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 AstraZeneca
14.3.3 Novartis
14.3.4 Ipsen
14.3.5 Merck
14.3.6 Mylan
14.3.7 Fresenius
14.3.8 Apotex Holdings
14.3.9 Novetide
14.3.10 Amneal Pharmaceuticals
14.3.11 Dr. Reddy's Laboratories